Is Kintara Therapeutics A Hidden Gem? Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results